Loading...

Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers

Therapies inhibiting receptor tyrosine kinases (RTKs) are effective against some human cancers when they lead to simultaneous downregulation of PI3K/AKT and MEK/ERK signaling. However, mutant KRAS has the capacity to directly activate ERK and PI3K signaling, and this is thought to underlie the resis...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Ebi, Hiromichi, Corcoran, Ryan B., Singh, Anurag, Chen, Zhao, Song, Youngchul, Lifshits, Eugene, Ryan, David P., Meyerhardt, Jeffrey A., Benes, Cyril, Settleman, Jeffrey, Wong, Kwok-Kin, Cantley, Lewis C., Engelman, Jeffrey A.
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Clinical Investigation 2011
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3204842/
https://ncbi.nlm.nih.gov/pubmed/21985784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI57909
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!